Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...

Carillon Eagle Growth & Income Fund highlighted stocks like Medtronic plc (NYSE:MDT), in the second quarter 2024 investor letter. Medtronic plc (NYSE:MDT) develops, manufactures, and distributes ...

Investors signalled that they were pleased with Medtronic plc's (NYSE:MDT) most recent earnings report. Looking deeper at the numbers, we found several encouraging factors beyond the headline ...

Elixir was comparing its implant against Medtronic’s Resolute Onyx zotarolimus, a stent that releases the immunosuppressant drug zotarolimus. After 12 months, the DynamX bioadaptor, which instead ...

A strategy of drug-coated balloon (DCB) angioplasty with rescue stenting did not achieve noninferiority compared with intended drug-eluting stent (DES) deployment for patients with de novo, noncomplex ...

Patients undergoing PCI for chronic or acute coronary syndrome (CCS or ACS, respectively) were randomized in a 1:1 fashion to undergo PCI with a DynamX sirolimus-eluting bioadaptor (n = 1,201) or a ...

The FDA has approved a new type of stent designed specifically for infants and young children—including neonates born with congenital heart defects—that’s designed to expand in size as the ...

Ajizian held multiple positions in his more than nine years at Medtronic. In 2020, the company made Ajizian CMO of patient monitoring. Two years later, Medtronic outlined plans to spin off its ...

CHARLOTTE — Newly approved medical technology offered at Atrium Health has helped a local man get back on his feet after a stent in his artery was blocked by scar tissue. Stan Ciepcielinski is ...

Medtronic (NYSE:MDT) has had a great run on the share market with its stock up by a significant 13% over the last month. We, however wanted to have a closer look at its key financial indicators as ...

Transfemoral carotid artery stenting (TFCAS) carries important perioperative risks. Outcome prediction tools may help guide clinical decision‐making but remain limited. We developed machine learning ...

Not all Protege models are created equal. While the vehicle has a strong reputation overall, certain model years have been reported to have more issues than others. So for today, we highlight the ...